Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep-Oct;96(5):344-7.
doi: 10.1007/BF03404029.

Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users

Courtney L C Collins  1 , Thomas Kerr, Mark W Tyndall, David C Marsh, Patricia S Kretz, Julio S Montaner, Evan Wood
Affiliations

Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users

Courtney L C Collins et al. Can J Public Health. 2005 Sep-Oct.

Abstract
in English, French

Many cities are experiencing ongoing infectious disease epidemics and substantial community harm as a result of illicit drug use. In an effort to reduce these public order and public health concerns, consideration has been given to the opening in Vancouver of a safer smoking facility (SSF). The present review was conducted to examine if there is a rationale to support the evaluation of a SSF in the Canadian context. Available evidence suggests that conventional drug control strategies are insufficient to address the health and community harms of non-injection drug use, and that the public order benefits of supervised injection facilities may be relevant to SSFs. In addition, there is persuasive evidence to suggest there is potential for blood-borne disease transmission through the sharing of smoking paraphernalia, and the potential for SSFs to address this concern is a pressing public health question. Also relevant to this topic are interventions to prevent transition into injection drug use, and SSFs may also be evaluated as a potential strategy to address this concern.

Plusieurs villes doivent composer avec des épidémies continues de maladies infectieuses et les dommages importants causés par l’utilisation de drogues illicites. Afin de réduire le nombre d’infractions à l’ordre public et d’apaiser les préoccupations en matière de santé publique, on a envisagé la création, à Vancouver, d’installations sécuritaires pour les fumeurs de drogues illicites (ISFDI). La présente évaluation avait pour but d’examiner s’il s’avérait justifié d’appuyer l’évaluation d’une ISFDI dans le contexte canadien. Les preuves disponibles révèlent que, d’une part, les stratégies antidrogues habituelles ne suffisent pas à contrer les effets sur la santé et la collectivité de l’utilisation des drogues non injectables et que, d’autre part, les effets positifs de la création de sites d’injection sur le maintien de l’ordre public peut justifier la création d’ISFDI. De plus, certaines données probantes convaincantes laissent supposer qu’il pourrait y avoir des répercussions positives sur la transmission de maladies à diffusion hématogène qui découlent du partage des articles des fumeurs et la possibilité que les ISFDI puissent remédier à cette situation constitue une question de santé publique prioritaire. Les interventions visant à prévenir le passage aux drogues à injection représentent un autre sujet pertinent à l’étude de la présente question; on pourrait également évaluer les ISFDI comme un moyen stratégique éventuel pour corriger cette situation.

PubMed Disclaimer

References

    1. Strathdee SA, Galai N, Safaeian M, Celentano DD, Vlahov D, Johnson L, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Arch Intern Med. 2001;161:1281–88. doi: 10.1001/archinte.161.10.1281. - DOI - PubMed
    1. Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003;168(1):19–24. - PMC - PubMed
    1. van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study. BMJ. 1998;317(7156):433–37. doi: 10.1136/bmj.317.7156.433. - DOI - PMC - PubMed
    1. Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: Prevalence, Risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J Infect Dis. 2000;182(6):1588–94. doi: 10.1086/317607. - DOI - PubMed
    1. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155(7):645–53. doi: 10.1093/aje/155.7.645. - DOI - PubMed

MeSH terms